2019
Karo Pharma publishes prospectus relating to the rights issue
Karo Pharma publishes prospectus relating to the rights issue
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South…
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2 billion
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2 billion
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South…
EXTRAORDINARY GENERAL MEETING IN KARO PHARMA AKTIEBOLAG ON 20 SEPTEMBER 2019
STOCKHOLM, 20 September 2019 At today’s extraordinary general meeting in Karo Pharma, the following resolution was passed. The general meeting…
Karo Pharma’s planned rights issue is intended to amount to approximately SEK 2 billion
As communicated on 12 September 2019, Karo Pharma Aktiebolag (”Karo Pharma”) has completed its acquisition of Trimb Holding AB. The…
Karo Pharma completes the acquisition of Trimb and carries out management changes
Karo Pharma Aktiebolag (”Karo Pharma”) today announces that the acquisition of all the shares of Trimb Holding AB (“Trimb”) from…
The Swedish Competition Authority approves Karo Pharma’s acquisition of Trimb and Karo Pharma continues the company’s efforts related to internalis...
Karo Pharma Aktiebolag (the ”Company” or ”Karo Pharma”) today announces that the acquisition of all the shares of Trimb Holding…
NOTICE OF EXTRAORDINARY GENERAL MEETING IN KARO PHARMA AKTIEBOLAG
The shareholders of Karo Pharma Aktiebolag, reg. no 556309-3359, are given notice of an Extraordinary General Meeting, to be held…